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Interpretative Summary 1 
Herd-level prevalence of selected endemic infectious diseases of dairy cows in Great 2 
Britain 3 
Velasova 4 
There is a need for reliable nationwide information on dairy cattle health in Great Britain 5 
(GB). The aim of this study was to estimate the herd-prevalence of selected endemic 6 
infectious diseases in the population of GB dairy herds. Our results show that dairy cows 7 
across GB are frequently exposed to the studied pathogens and showed some geographical 8 
variation. More than half of farms showed evidence of exposure to bovine viral diarrhoea 9 
virus (BVDV) (66%), Mycobacterium avium subspecies paratuberculosis (Johne’s disease) 10 
(68%), bovine herpesvirus type 1 (BHV-1) (62%) and Coxiella burnetii (80%). On 11 
approximately 50% of farms, antibodies against Leptospira hardjo and Salmonella spp were 12 
detected. Further, almost all farms (95%) showed evidence of exposure to Ostertagia 13 
ostertagi, 55% farms to Fasciola hepatica and 46% farms to Neospora caninum. Given the 14 
burden to efficient production that those pathogens pose, and in some cases their public 15 
health implications, the implementation of measures to control and possibly eliminate some 16 
of the studied pathogens should be given consideration. 17 
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ABSTRACT 39 
In order to implement appropriate and effective disease control programs at national level, 40 
up-to-date and unbiased information on disease frequency is needed. The aim of this study 41 
was to estimate the prevalence of selected endemic infectious diseases in the population of 42 
dairy herds in Great Britain. Bulk milk tank (BMT) samples from 225 randomly selected 43 
dairy farms stratified by region and herd size were tested for antibodies against bovine viral 44 
diarrhoea virus (BVDV), bovine herpesvirus type 1 (BHV-1), Mycobacterium avium 45 
subspecies paratuberculosis (MAP), Leptospira hardjo (L. hardjo), Salmonella spp., Coxiella 46 
burnetii (C. burnetii), Fasciola hepatica (F. hepatica), Neospora caninum (N. caninum) and 47 
Ostertagia ostertagi (O. ostertagi). Furthermore, the presence of BVDV, C. burnetii and 48 
Chlamydia-like organisms was determined by polymerase chain reaction (PCR). The 49 
apparent herd prevalence was estimated as a weighted proportion of positive farms. For some 50 
of the pathogens, the true prevalence was calculated by adjusting for the herd level sensitivity 51 
and specificity of bulk milk tests and the expected ability of the diagnostic test to classify as 52 
positive or negative farms above or below a minimum proportion of positive animals among 53 
those in milk. Amongst unvaccinated farms, the true prevalence of BMT antibodies against 54 
BVDV (number of farms, n=102) was estimated at 66% (95% Confidence Interval, CI: 56-55 
77), MAP (n=222) 68% (95% CI: 59-77), BHV-1 (n=118) 62% (95% CI: 52-73), L. hardjo 56 
(n=111) 47% (95% CI: 34-60) and Salmonella spp. (n=209) 48% (95% CI: 39-56). The 57 
apparent prevalence of BMT antibodies against C. burnetii (n=221) was 80% (95% CI: 75-58 
85), F. hepatica (n=224) 55% (95% CI: 48-62), N. caninum (n=222) 46% (95% CI: 38-54), 59 
and O. ostertagi (n=221) 95% (95% CI: 91-98). BVDV (n=225), C. burnetii (n=220) and 60 
Chlamydia-like (n=220) antigens were detected on 5% (95% CI: 2-9), 29% (95% CI: 21-36) 61 
and 31% (95% CI: 24-38) of farms, respectively. Our results show that dairy cows across GB 62 
are frequently exposed to the studied pathogens, which are endemic at high levels with some 63 
geographical variations. These prevalence estimates provide a much needed basis to assess 64 
whether nationwide control programs for the studied pathogens are justified by their potential 65 
economic, environmental and public health implications. Should surveillance and control 66 
programs be initiated, the estimates presented here are a baseline against which progress can 67 
be assessed.  68 
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INTRODUCTION 
A number of infectious diseases of dairy cows such as bovine viral diarrhoea (BVD), 
Johne’s disease caused by Mycobacterium avium subspecies paratuberculosis (MAP), 
infectious bovine rhinotracheitis (IBR) and liver fluke are generally regarded as being 
widespread and endemic in the United Kingdom (Carslake et al., 2011;  Sekiya et al., 2013). 
These disease are known to have a significant impact on dairy production due to their effect 
on fertility (Fray et al., 2000;  Lanyon et al., 2014;  Walz et al., 2015), milk production 
(Charlier et al., 2007;  Tiwari et al., 2007;  Richardson and More, 2009;  McAloon et al., 
2016) and subsequently on culling (Wilson et al., 1993;  Tiwari et al., 2005;  Murphy et al., 
2006;  Smith et al., 2010).  
In Great Britain (GB), in 2005, the total costs of cattle endemic diseases (disease, 
control and prevention) was estimated to range from £800,000 ($984,675) for Johne’s disease 
and Pasteurellosis to £39.6 million ($48.7 million) per annum for BVD (Bennett and Ijpelaar, 
2005). With the exception of bovine tuberculosis (bTB) in GB and BVD in Scotland, 
controlling such diseases is voluntary for GB farmers. The need to control endemic infectious 
disease can however be overlooked by farmers as it can be difficult to associate their 
presence with visible losses. This is often because clinical signs associated with such diseases 
on a given animal in an infected herd are absent, mild or non-specific, leading towards a 
general acceptance of their occurrence on dairy farms in endemic areas (Richardson and 
More, 2009;  Cummings et al., 2010;  Carslake et al., 2011;  Statham, 2011). In such cases, 
from the farmers’ perspective, there is often very little, if any, financial incentive to control 
the disease (Stott et al., 2005). Nevertheless, examples from European countries suggest that 
the control or elimination of some of these pathogens (e.g. bovine herpesvirus type 1 in 
Scandinavian countries and Austria, BVDV in Sweden) can be achieved and would be 
beneficial (Ackermann and Engels, 2006;  Lindberg et al., 2006).  
When control programs are implemented, it is important, that they are accompanied 
by continuous monitoring of herd status to assess the effectiveness of the program and 
progress towards goals. This can be achieved through serological testing at herd level 
(Lindberg and Alenius, 1999;  Houe et al., 2006). Testing of bulk milk samples is a 
particularly cost-effective strategy and has become part of surveillance and disease control 
programs for a number of endemic infectious diseases of dairy cattle (Paton et al., 1998;  
Leonard et al., 2004;  Kim et al., 2005;  Nielsen and Nielsen, 2012;  Booth et al., 2013;  
Sekiya et al., 2013). 
The application of a suitable disease control or elimination program at national or 
regional level and the monitoring of the progress of that program should be based on 
knowledge of the baseline frequency and distribution of the disease in the population (Dohoo 
et al., 1994;  Ackermann and Engels, 2006;  Humphry et al., 2012;  Sayers et al., 2015). Such 
estimates can allow informed decisions on the justification of a program at national level and 
provide a baseline against which the impact of the control program can be assessed. With the 
exception of BVD in Scotland, for which a survey of Scottish dairy farms has recently been 
carried out to inform the Scottish BVD elimination program (Humphry et al., 2012), 
presently, in GB, there is a lack of reliable and up-to-date estimates of the prevalence of 
endemic diseases in the national dairy herd. This is because, for the majority of endemic 
diseases, there is no active disease surveillance in place. A number of private and public 
routine recording systems exist; however, at national level, the information they provide is 
likely to be biased (Velasova et al., 2015).  
In addition to these ongoing recording systems, one-off surveys are often carried out 
(Paton et al., 1998;  Pritchard, 1999;  Davison et al., 2005;  Salimi-Bejestani et al., 2005;  
Woodbine et al., 2009b;  Williams and Winden, 2014), but although useful, their results 
should be interpreted with caution because of issues such as non-probabilistic selection of 
studied farms (Paton et al., 1998;  Woodbine et al., 2009b;  Williams and Winden, 2014) and 
failure to adjust prevalence estimates for the study design (Paton et al., 1998) or for test 
performance  (Davison et al., 2005;  Woodbine et al., 2009a;  Williams and Winden, 2014). 
Furthermore, one-off studies are only useful for a limited period of time, as the level of 
endemicity can change as a result of the implementation of control measures and changes in 
the dairy industry, the more apparent of which are increased herd size, genetic selection and 
application of new technological innovations (Barkema et al., 2015). It is therefore 
reasonable to assume that the few available estimated prevalence figures could no longer be 
accurate.  
Accordingly, the aim of this study was to generate new information on the prevalence 
and distribution of selected major infectious diseases of dairy cows at national level to 
provide a basis for a future monitoring of disease trends over time and for the implementation 
of suitable and effective disease control or elimination programs at national level.  
 
MATERIAL AND METHODS 
Study Population and Sampling Design 
A nationwide cross-sectional study of commercial dairy herds was conducted in Great 
Britain from April 2014 to March 2015. The study population was selected by means of 
stratified random sampling from a sample frame comprising 10,491 dairy farms, representing 
approximately 95% of the total population of all dairy farms in GB, held by the dairy industry 
(AHDB Dairy, division of the Agricultural and Horticultural Development Board). The farms 
were stratified by region (North England, Midlands, South East England, South West 
England, Scotland and Wales) and herd size (small: < 50 cows, medium: 50 - 149 cows, 
large: ≥ 150 cows). Equal number of farms within each stratum was selected using simple 
random sampling. The total number (n) of farms to study was calculated as follows 
(EpiCentre, IVABS, Massey University, New Zealand): 
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Where e is the number of strata, ni is the number of farms in strata i, pi is the expected 
prevalence in strata i (50% was used as worst-case scenario), N is the total number of farms 
in the population, AE is absolute acceptable error (7%), Z is a constant corresponding to a 
95% confidence interval (1.96) and wi is a weighting factor of each stratum.  For purpose of 
sample size calculation, perfect sensitivity and specificity of the diagnostic tests were 
assumed. A total sample of 200 farms was found to be sufficient to generate the desired 
estimates and it was decided to aim to recruit 250 farms.  
Based on previous experiences of the dairy industry, it was expected that around 20% 
of farmers contacted would be willing to participate in the study. The selected farmers were 
contacted by post, receiving information about the project and their participation. Farmers not 
responding to the initial letter received a reminder. Cattle veterinary practitioners were also 
informed about the project through the British Cattle Veterinary Association (BCVA) 
newsletter and by email and were also asked to encourage their clients to participate if they 
received a letter inviting them. Farmers who agreed to participate were included in the study 
and the status of their farms with respect to ten different pathogens was assessed. Selection of 
specific pathogens was based on the results of a workshop run by the Royal Veterinary 
College in April 2012. In the workshop, the participants were asked to identify and rank 
cattle health conditions considered important for individual farmers and the dairy industry 
and for which no reliable and up-to-date nationwide estimates were available (Velasova et al., 
2015). Additionally, five more pathogens for which no up-to-date nationwide estimates were 
identified and which could be detected using bulk milk samples were included.  
 
Ascertainment of Disease Status 
Farm level status regarding ten different pathogens was assessed by testing a single or 
repeated bulk milk tank (BMT) samples for the presence of specific antibodies (Ab) (Table 
1). In addition, for three of the pathogens direct detection of the antigen in bulk milk was 
carried out. 
From each farm, a BMT sample of approximately 30 mL was collected and kept 
refrigerated until arrival at the laboratory. On arrival fresh milk samples were put into 
refrigerated storage set at the temperature between 1°C – 7°C. To each sample 5 mL of 
Bronopol preservative was added. Commercially available enzyme linked immunosorbent 
assays (ELISAs) were performed according to the manufacturers’ instructions. If there was 
an option for short and long incubation, the long incubation was used. The results were 
calculated according to the manufacturer’s instructions either as 1) percent positivity 
calculated as the ratio of the optical density of the sample (ODS) to the mean optical density 
of the positive control (ODPC) x 100 or as, 2) the percentage inhibition calculated as (1-
ODS/ODNC) x 100, where ODNC is the mean optical density of the negative control.  
The presence of BVDV antigen was studied by means of a real-time polymerase chain 
reaction (real-time PCR) protocol (TaqVet® BVDV screening test - LSI, France). The 
presence of Coxiella burnetii (C. burnetii) antigen was assessed by means of an in-house 
real-time PCR protocol developed by Klee et al. (2006). An in-house real-time PCR (16S 
Chlamydiales PCR) according to Lienard et al. (2011) was also used to detect Chlamydia-like 
organisms. 
All the analyses were carried out on a single BMT sample with the exception of the 
detection of antibodies against MAP and Fasciola hepatica (F. hepatica) and the detection of 
BVDV antigen, which were carried out on four samples collected at three monthly intervals. 
This was carried out to increase the detection of positive farms considering the low diagnostic 
performance of bulk milk ELISA tests for the detection of MAP (van Weering et al., 2007) 
and F. hepatica (Reichel et al., 2005) and higher prevalence of BVDV amongst young stock 
(Booth et al., 2013). 
 
Data Collection 
A standardised questionnaire was used to gather information on general farm 
characteristics (i.e. herd size, production type), vaccination status, the main herd health 
problems as perceived by the farmer at the time of the visit and the farmer’s knowledge of the 
disease status of the farm for each disease in question. With respect to the disease status, the 
farms were divided into five categories: 1) disease definitely present (based on previous 
laboratory testing or abattoir monitoring), 2) disease present but unsure (no previous 
laboratory testing was carried out), 3) disease definitely not present (previous laboratory 
testing was carried out), 4) disease not present but unsure; and 5) unknown disease status. 
The questionnaire was designed in consultation with two veterinary practitioners and was 
piloted on four farms prior to use. Questions, which appeared to be unclear to farmers, were 
rephrased to improve the clarity. Interviews were carried out by seven interviewers (three 
qualified veterinarians and four final year veterinary students), all of whom were trained to 
ensure consistency and robustness of the collected data. 
 
Data Analysis 
All questionnaire data and the results of the laboratory testing were entered into a 
Microsoft Access 2007® (Microsoft Corp., Redmond, WA, USA) database. The accuracy of 
information in the database was cross-checked with the questionnaire. All categorical 
variables were summarised using frequencies and percentages. All continuous variables were 
checked for deviations from the normal distribution using histograms and the normality test 
for skewness and kurtosis. They were summarised using frequencies and medians with ranges 
(minimum and maximum). The descriptive statistics were carried out using Stata 11.2® 
(StataCorp, Texas, USA) software. 
 
Prevalence Estimation - Single Disease Testing. For the estimation of prevalence at 
herd level, the results of assays were dichotomised as positive/negative based on the cut offs 
summarised and presented in Table 2. The apparent herd prevalence (p) of individual 
pathogens at national level was calculated as the total number of positive herds divided by the 
total number of herds sampled weighted to account for the stratified study design. Sampling 
weights were calculated for each stratum as: 1/probability of a farm being selected. The 
probability of a farm being selected was calculated as proportion of farms studied in each 
stratum from the total number of farms in the stratum using the AHDB Dairy sampling frame 
described above. The population prevalence (p) can be calculated as follows (EpiCentre, 
IVABS, Massey University, New Zealand): 
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Where e is the number of strata, Ni is the number of farms in the population in stratum 
i, pi is the estimated proportion of farms with the condition of interest in stratum i, N is the 
total number of farms in the population (AHDB Dairy sampling frame). The weighted 
proportions and their 95% confidence intervals adjusted for the study design by estimating 
the standard error using linearization method with a first order Taylor approximation of the 
point estimates were obtained in Stata 11.2 software (StataCorp, 2013).  
The true herd prevalence was calculated for those conditions for which it was 
considered biologically meaningful to dichotomise farms as not infected or infected and for 
which reliable information on the diagnostic test performance was available. The latter 
information included: a) herd level sensitivity (Se) and specificity (Sp) of the diagnostic tests 
used; and b) a positive cut off value (as per test manufacturer instruction) to classify herds as 
positive or negative above or below this threshold. The point estimates and confidence 
intervals were adjusted for the Se and Sp of the diagnostic tests as described by Rogan and 
Gladen (1978). Information on herd level Se and Sp of the diagnostic tests as well as the 
minimum proportion of positive animals for the establishment of herd sensitivity and 
specificity was obtained either directly from the manufacturers or through available literature 
and is summarised in Table 2. In the case of the prevalence of Ostertagia ostertagi (O. 
ostertagi), F. hepatica, Neospora caninum (N. caninum) and C. burnetii only apparent 
prevalence is presented, as no reliable information on the respective diagnostic tests Se and 
Sp were obtained. All PCR tests were assumed to have 100% Se and Sp. Because of the 
inability of the antibody assays that were performed to distinguish between vaccinated and 
unvaccinated herds, vaccinated herds and herds for which vaccination status was unavailable 
were removed from the analysis.  
Correlations between studied pathogens on unvaccinated farms were assessed by Phi 
correlation coefficient (ϕ) calculated as the square root of chi-square divided by n, the total 
number of observations (Olivier and Bell, 2013). A chi-squared test was performed to assess 
the association of herd status (positive/negative) with region or herd size. Variations in the 
prevalence taking into account the effect of both region and herd size (independent variables) 
were assessed using logistic regressions. The strengths of the associations was measured by 
calculating adjusted odds ratios (ORs) and their confidence intervals (CI). Statistical 
significance of the associations of both independent variables to the farm status was tested 
using a Wald test at a relaxed significance level alpha = 5%. 
 
Repeated Quarterly Testing. The apparent and true herd prevalence of antibodies 
against MAP and F. hepatica and the presence of BVDV at each quarterly test were 
estimated as described above. Only farms that completed all four quarterly tests were 
included in the analysis. To estimate overall period prevalence, a farm was considered 
positive if at least one of the samples tested positive in a given quarterly test during the 
period of 12 months. The true period herd prevalence was then calculated based on a 
combined Se and Sp of the tests in parallel as: Secombined = Se x n - (Se)
n and Spcombined = Sp
n, 
where n= number of tests carried out. Because not all the farms participated in all quarterly 
tests, the calculations of combined Se and Sp were performed based on a minimum of two 
quarterly tests carried out. The Secombined and Spcombined of MAP ELISA test in parallel were 
calculated as 1.0 and 0.85 respectively. For the BVDV PCR test Secombined and Spcombined of 
one were used.  
Farmers’ perception. Positive and negative predictive values (PPV and NPV) were 
calculated as the proportion of farms on which farmers correctly classified the status of the 
farm with respect to the pathogens under study using the results of the BMT as the gold 
standard. Farms vaccinating against the studied pathogens or those were farmers did not 
know the status of the tested pathogens were excluded from the calculations.  
 
Spatial Analysis 
Choropleth maps showing the distribution of positive herds across the studied regions 
were generated, by dividing the number of positive herds by the number of herds tested 
within each region (where possible adjusted for the performance of the diagnostic tests used), 
using ArcGIS 10 (ESRI Inc., CA, USA, 2010) software. Presence of spatial autocorrelation 
was tested using the univariate Moran’s I test for global spatial autocorrelation and Queen 
contiguity (i.e. considering as neighbouring units those that have any point such as 
boundaries or corners in common). To account for the variation in number of farms tested 
and the underlying population structure, the prevalence estimates were adjusted towards the 
overall average by applying the empirical Bayes smoothing (Anselin et al., 2004;  Anselin, 
2004-2005). Statistical significance of the Moran’s I was tested using Monte Carlo 
randomisation with 9,999 permutations. The analyses of global spatial autocorrelation were 
carried out using the GeoDa 1.6.7 software (https://geodacenter.asu.edu).  
Areas with significantly higher or lower proportion of BMT positive farms (clusters) 
were identified using a spatial scanning method, the scan statistics. The testing was 
performed using Bernoulli probability model by Kulldorff (1997) in SatScanTM version 9.4.2 
(www.satscan.org.). The maximum cluster size tested was 50% of the population at risk. The 
geographic information was based on the farm postcode (easting and northing coordinates) 
corresponding to the farm address registered within the AHDB Dairy database collected as 
part of the recruitment process. Identified clusters were considered significant at P < 0.05, 
based on Monte Carlo hypothesis testing with 9,999 permutations. 
The project was approved by the Ethics and Welfare committee at the Royal Veterinary 
College (approval number URN 2013 0097H). 
 
RESULTS 
Farm Recruitment 
Of the 1483 selected dairy farms, 553 farms responded (37% response rate); 279 
negative and 274 positive answers. Of the 274 farms that agreed to participate, 225 farms 
were studied (had milk sample tested for some or all of the diseases and completed the 
questionnaire), representing approximately 2% of the total population of dairy farms in GB. 
The remaining 49 farms that initially answered positively either went out of milk production, 
were no longer contactable or no longer interested in the study for various reasons.  
 
Farm Characteristics 
The median herd size was 133 adult cows and ranged from 14 to 603. Approximately 
half (117/225) of the farms were mixed dairy farms (dairy farms with other production 
animals, i.e. beef or sheep) and the majority of the farms (93%, 209/225) were conventional 
(as opposed to organic) dairy producers. One hundred and sixty-four farms (73%) managed 
their milking herd as one production group and the remaining farms had two or more groups 
of high and low yielding cows. The average milk yield per cow per year in 2013 was 7613.2 
litres (median=7822.1, range from 3100 to 11679 litres). Information on calving intervals was 
recorded from 205 farms with median of 406 days (range from 310 to 474 days). On majority 
of farms cows calved all year round (74%, 165/224). The most common grazing system was 
grazing in summer and housed in winter (89%, 200/225). On 13 (6%) farms, cows were kept 
indoor all year round and on remaining farms, cows were kept outdoor all year round. 
Cubicles were the most common (79%, 164/208) type of housing for milking cows, with 27 
(13%) farms housing milking cows in straw yards and the remaining farms using both type of 
housing. One hundred and seven farms (48%) purchased a new stock during a period of 12 
months prior to the farm visit.  
 Point Prevalence  
Initial BMT samples were obtained for all farms between July 2014 and March 2015, 
with 144 farms (64%) tested between July and September 2014. The estimated herd 
prevalence of the studied pathogens based on the presence of antibodies (on unvaccinated 
farms) or antigen (all farms) in the initial BMT samples was high with higher proportion of 
positive farms found amongst medium (50-150 cows) and large (≥150 cows) herds (Table 3). 
The true prevalence of antibody positive unvaccinated farms ranged from 48% (95% CI: 40-
56) to 68% (95% CI: 61-76) for Salmonella spp and MAP, respectively. Of the nine BVDV 
antigen positive farms, seven farms vaccinated against BVDV. Amongst BVDV 
unvaccinated farms, two farms were both BVDV antigen and antibody positive. Of the 57 C. 
burnetii antigen positive farms, 55 farms had also antibodies detected. The distribution of 
ELISAs antibody levels expressed as percent positivity or percent inhibition (BVDV) is 
presented in Figure 1. Of the pathogens tested, amongst unvaccinated farms, a correlation of 
positive status was found between: (1) BVDV antibody and BHV-1, Leptospira hardjo (L. 
hardjo) and F. hepatica; (2) BHV-1 and MAP and L. hardjo; and (3) C. burnetii antibody and 
antigen positive farms (Table 4). Very low positive correlation was detected between BVDV 
antibody and antigen.  
 
Associations of prevalence with region and herd size 
In the univariable analysis, region was significantly associated with testing positive to 
BVDV antibody (P = 0.01), BVDV antigen (P = 0.03), L. hardjo (P < 0.001), MAP (P = 
0.04), Salmonella spp (P = 0.001), C. burnetii antibody (P = 0.01), Chlamydia-like organisms 
(P = 0.04) and F. hepatica (P < 0.001). Herd size was significantly associated with testing 
positive to C. burnetii antibody (P < 0.001), F. hepatica (P = 0.02) and O. ostertagi (P = 
0.05).  
In the multivariable analysis (Table 5), taking into account the effect of herd size, 
farms located in Wales had significantly higher odds of being BVDV antibody positive 
compared to the farms in South East England (OR = 14.2, 95% CI: 2.7 – 75.0). The odds of a 
farm being positive to BHV-1 was increased for farms located in Scotland (OR = 6.2, 95% 
CI: 1.1-36.2) and Wales (OR = 4.3, 95% CI: 1.3 – 14.0); and of MAP for farms in South 
West England (OR = 3.3, 95% CI: 1.3 - 8.6). Farms located in the central and northern parts 
of the country had significantly increased odds of being positive to L. hardjo compared to the 
farms in South East England. Large herds and farms located in South West England (OR = 
3.8, 95% CI: 1.4 – 10.3), North England (OR = 4.3, 95% CI: 1.5 – 12.4), Scotland (OR = 6.2, 
95% CI: 1.8 – 22.0) and Wales (OR = 7.1, 95% CI: 2.6 – 19.6) had significantly increased 
odds of being positive to Salmonella spp. Both herd size and region were significantly 
associated with being positive to C. burnetii, with higher odds detected for medium and large 
herds and farms located in South West England, Wales, Midlands and North England (Table 
5). Accounting for the effect of region, large herds were less likely to be positive to F. 
hepatica compared to the small herds (OR = 0.2, 95% CI: 0.1 – 0.9). Odds of being positive 
to F. hepatica were significantly increased for all regions but Midlands when compared to 
South East England. BVDV antigen and O. ostertagi were dropped from the multivariable 
analysis due to omitted observations in some of the categories of region or herd size.   
 
Repeated Quarterly Testing 
 The quarterly testing for the presence of BVDV antigen and antibodies against MAP 
and Fasciola hepatica in BMT samples was carried out between October 2014 and 
November 2015. The median interval between the second, third and fourth quarterly test was 
90, 92 and 89 days, respectively with a minimum of 19 days and a maximum of 190 days 
between any two tests carried out. The overall prevalence of BVDV and antibodies against 
MAP and F. hepatica in bulk milk, based on all four tests results, was estimated for 203, 206 
and 206 farms respectively. The results of prevalence at each quarterly testing as well as the 
overall (period) prevalence during the whole study period are presented in Figure 2. The true 
prevalence of BVDV antigen positive farms was 5%, 11%, 11% and 12%, and of MAP 
antibody positive farms was 68%, 72%, 83% and 80%, at each quarterly test, respectively. 
The apparent prevalence of F. hepatica antibody positive farms at first, second, third and 
fourth test was 55%, 60%, 57% and 56% respectively. During the whole study period, the 
true prevalence of farms testing positive at least once to BVDV antigen or antibodies against 
MAP was 19% (95% CI: 13 – 26) and 89% (95% CI: 81 – 94), respectively. The apparent 
period prevalence of F. hepatica was 67% (95% CI: 61– 73). 
 
Farmers’ Knowledge of Disease Status 
Approximately 19% (42/224) of farms were members of one of the accredited herd 
health schemes and 3% (7/224) of farms were working towards one at the time of the visit. 
Farmers’ knowledge of the status of their herds with respect to the studied pathogens is 
summarised in Figure 3. Amongst unvaccinated farms, farmers believed MAP, F. hepatica 
and BVD to be present on 55%, 46% and 30% of farms, respectively. Of the studied 
pathogens, most frequently reported problems were due to MAP (41% of farms), whereas no 
problems due to Salmonella spp., C. burnetii or O. ostertagi were reported (Figure 3). 
Percentage of farms, where farmers correctly believed the disease in question was present 
that actually tested positive (positive predictive value) was high for C. burnetii (100%), O. 
ostertagi (97%) and BVDV antibody (92%) but very low for BVDV antigen (5%), Table 6. 
High negative predictive value of the farmers’ perception was estimated for BVDV antigen 
(96%).   
 
Spatial Distribution 
Accounting for the vaccination status, herds that tested positive for the individual 
pathogens were found in all studied regions. However, the variation in the distribution of the 
positive herds was marked across the regions (Figure 4 a,b,c) with the lowest estimates found 
mostly in the South East England. Global spatial autocorrelation of positive unvaccinated 
farms was detected for BVDV antibodies (I = 0.23, P = 0.02), F. hepatica (I = 0.22, P = 
0.008) and Salmonella spp. (I = 0.18, P = 0.02). Spatial autocorrelation of C. burnetii PCR 
positive farms was also detected (I = 0.03, P = 0.02). By means of the Scan statistic, both low 
and high-risk clusters of positive unvaccinated farms were found for F. hepatica, L. hardjo, 
Salmonella spp., and for BVDV antibodies. Further, one high-risk cluster for BVDV antigen 
and O. ostertagi, and one low-risk cluster for C. burnetii antibody positive farms were found 
(Figure 5 a,b). All low-risk clusters were located in the South East England.  
 
DISCUSSION 
To inform decisions regarding disease priorities and suitable control programs and to 
allow for monitoring of disease trends over time, reliable and up-to-date information on 
disease prevalence is highly desirable. With this in mind, the present study was designed to 
provide prevalence estimates representative of the national GB dairy herd for a number of 
infectious diseases assumed to be endemic. Participation in the study was voluntary. 
However, when compared nationally, although the estimated weighted average herd size of 
187 cows was slightly higher than that of 144 cows for the GB dairy herd; the estimated 
average annual milk yield was comparable with the national estimate of 7,535 litres  
(DairyCo, 2013). This is suggesting that the data where not noticeably biased in this respect. 
The use of stratified sampling by region and herd size has further allowed us to produce 
national prevalence estimates with smaller standard errors compared to a non-stratified study 
of the same size.  
The results confirm that the studied pathogens are spread widely across GB and that, 
at the time of the study, a large proportion of the dairy herds in GB had previously been 
exposed to them. The results further suggests that active disease transmission is occurring 
amongst the dairy cattle population and that available control measures are either not being 
implemented or not being effective. The estimated prevalence values broadly agree with 
those reported from other countries, where studied pathogens are considered endemic, 
suggesting similar pathogen dynamics (Boelaert et al., 2000;  Muskens et al., 2000;  Nielsen 
et al., 2000;  Alonso-Andicoberry et al., 2001;  Otranto et al., 2003;  van Schaik et al., 2003;  
Kampa et al., 2004;  Scott et al., 2006;  Talafha et al., 2009;  Habing et al., 2012;  Saa et al., 
2012;  Lombard et al., 2013;  O' Doherty et al., 2013;  Agger and Paul, 2014;  van Engelen et 
al., 2014;  Sayers et al., 2015;  Fernandes et al., 2016), except for higher prevalence estimates 
of F. hepatica and N. caninum infections compared to some other countries (Sanderson et al., 
2000;  Cringoli et al., 2002;  O' Doherty et al., 2013;  Olsen et al., 2015). 
Bulk milk samples were used to assess herd status based on the presence of specific 
antibodies or antigen. Our prevalence estimates are therefore herd-level estimates and they 
are subject to misclassification bias as a result of suboptimal sensitivity or specificity of the 
tests applied at the level of the herd. Ascertainment of the infection status of a herd by means 
of testing a single milk sample from the bulk tank is well established and has obvious 
logistical and financial advantages. On the other hand, the use of bulk milk comes with 
limitations as the ability to identify infected herds (sensitivity) is compromised, in particular 
for pathogens which can be present in the herd at low within-herd prevalence level. In this 
situation, negative results should be interpreted as a herd with less than a minimum 
proportion of positive animals among those in milk needed for the expected ability of the 
diagnostic test to classify farm as positive. When possible, we tried to adjust the apparent 
prevalence obtained for the imperfect performance of the test using available values of herd-
level sensitivity and specificity. This information was however not available for some of the 
studied pathogens such as C. burnetii, F. hepatica, N. caninum and O. ostertagi. As a result, 
only estimates of their apparent prevalence are presented. In addition, we assumed all PCR 
tests to be 100% Se and Sp, which could have resulted in the misclassification bias. Another 
limitation is that the antibodies detected in BMT sample may be indicative of historical rather 
than active or recent infection (Duffell and Harkness, 1985;  Lindberg and Alenius, 1999;  
Booth et al., 2013;  Sayers et al., 2015) and that the bulk milk sample does not include the 
whole herd. Young stock, clinically ill cows and dry cows are excluded from the sample. As 
a result, for example, the prevalence of BVDV antigen in bulk milk can be underestimated 
due to premature culling of infected young stock (Bishop et al., 2010). Similarly, the 
prevalence of MAP can be underestimated due to the susceptibility of cows infected with 
MAP to secondary conditions (e.g. mastitis or lameness) (Villarino and Jordan, 2005) and the 
subsequent exclusion of cows treated with antibiotics from milk sampling and testing.  
Regional variations in prevalence of some of the studied pathogens have been 
reported previously (Paton et al., 1998;  Leonard et al., 2004;  Ryan et al., 2012;  Howell et 
al., 2015;  Sayers et al., 2015). Overall, we found lower proportion of the positive farms in 
the South East of England where cattle density is lower (< 10 dairy cows per 100 hectares of 
farmed land) compared to the other studied regions (CHAWG, 2012). Other factors, such as 
herd size, management practices (biosecurity, purchase of new stock), and environmental 
conditions (i.e. temperature, type of land) can be used to explain the observed regional 
differences in the number of positive farms. However, comparison at regional level has to be 
done with caution, as the present national study was not designed to generate prevalence 
estimates at regional level.  
A relatively high number of studied farms were vaccinated against BVDV, BHV-1 
and L. hardjo, which indicates farmers’ understanding of a need for disease control measures. 
Only the results of unvaccinated herds are presented as the diagnostic tests used in this study 
were unable to differentiate between vaccinated and infected farms. Further, the presence of a 
correlation between the positive status for BVDV antibodies, BHV-1, L. hardjo, MAP and F. 
hepatica is suggesting that there are similar risk factors for infections due to these pathogens, 
which is in agreement with the previous reports (Paton et al., 1998;  Kampa et al., 2004;  
Williams and Winden, 2014). The high level of antibodies against BVDV and  BHV-1 
detected on a number of farms is suggestive of the presence of active infection or in case of 
BVDV, also presence or recent removal of persistently infected (PI) animal(s) (Kampa et al., 
2004;  Booth et al., 2013). However, the detection of low positive correlation between BVDV 
antibody and antigen positive farms in this study is indicative of detection of historical 
infections on a number of farms, as the antibodies can persist in bulk milk up to three to four 
years in previously infected herds (Lindberg and Alenius, 1999). The observed variation in 
the level of BHV-1 BTM antibody detected agrees with the previous report of farms being 
either strongly positive or with very low or no antibody detected (Paton et al., 1998). 
Furthermore, the estimated prevalence of BHV-1 is almost identical to the values reported 
from previous surveys indicating the stability of the virus in the population of GB dairy farms 
(Paton et al., 1998;  Williams and Winden, 2014). 
The high apparent prevalence of BMT antibodies against O. ostertagi, F. hepatica and 
N. caninum is not surprising. It has been reported that O. ostertagi is present on all farms and 
that the majority of type 1 ostertagiosis infections occur during summer months (Sekiya et al., 
2013). Higher proportions of O. ostertagi and F. hepatica BMT antibody positive farms were 
found in the northern parts of GB. This is most likely due to the effect of environmental 
factors (i.e. higher rainfall in these regions in 2014 (Office, 2014) as well as differences in 
grazing practices (i.e. access to pasture and duration of grazing) (Sekiya et al., 2013). In 
relation to N. caninum, seasonal variation in the prevalence has been previously reported (O' 
Doherty et al., 2013). Due to limited financial resources, only a single testing was carried out 
which could have resulted in some positive farms being missed, especially on farms tested 
during early stages of the lactation (O' Doherty et al., 2013). However, in this study, the 
majority of the herds (74%) were calving all year round. Furthermore, the first testing was 
carried out between July 2014 and March 2015 with the majority (64%) of the samples tested 
between July and September 2014 minimising the number of false negative results on farms 
with seasonal calving. 
The prevalence of Salmonella spp, and C. burnetii in a population of dairy farms in 
GB was high. However, no farmer reported problems due to these pathogens, indicating that 
they are mostly subclinical. As a result, without routine screening, infected herds will remain 
undetected posing a risk for disease transmission, especially in areas with high cattle density. 
The differences in environmental and climatic conditions (i.e. type of landscape, cattle 
density, temperature, rainfall, wind) were also reported to play an important role in relation to 
the regional variations we observed for these pathogens (Davison et al., 2005;  Nusinovici et 
al., 2015). Similarly, diverse ecological niche and a wide hosts range for Chlamydia-like 
organisms have been reported (Taylor-Brown et al., 2015). In addition to their presence in 
environment, previous studies in GB have also observed the evidence of Chlamydia-like 
organisms in 18% of bovine placenta samples in Scotland (Wheelhouse et al., 2012) and in 
approx. 10% of bovine samples in England and Wales (Wheelhouse et al., 2015).  
The repeated testing for BVDV antigen and antibodies against MAP and F. hepatica 
allowed us to observe trends in antibody levels. The exposure of farms to F. hepatica 
appeared to be stable during the whole follow up period, suggesting the endemicity of the 
infection on the farms. In relation to MAP infections, changes from positive to negative or 
negative to positive status were observed on more than half of the farms during the follow up 
period. The changes could be due to the low diagnostic performance of the MAP ELISA (van 
Weering et al., 2007), purchase of seropositive animals on open farms or exclusion of dry or 
seropositive animals from the BMT testing. Changes in BVDV antigen status during the 
study period could also be due to a purchase or removal of infected animals from the herd or 
bulk milk sample at the time of the testing or due to a PI heifer entering the milking herd 
(Booth and Brownlie, 2012). The observed changes in prevalence of BVDV antigen and 
antibodies against MAP, together with the results of farmers’ perception of disease status 
highlight the importance and value of repeated testing in correctly identifying infected herds 
and hence appropriate control measures.  
Given the importance of accurate and reliable baseline data for the effective 
implementation and monitoring of disease control programs, the results of this study are 
particularly valuable. That is because the results of this study not only provide much needed 
baseline data for the control of endemic pathogens (for which monitoring is already 
underway in GB, i.e. BVDV), but also for other pathogens which are not presently being 
monitored at a national level in GB. 
 
CONCLUSIONS 
Dairy herds in Great Britain are frequently exposed to a number of endemic 
pathogens that are prevalent at high levels and exhibit some geographical variations. Given 
the burden to efficient production that those pathogens pose, and in some cases their public 
health implications, the implementation of measures to control and possibly eliminate some 
of these pathogens should be given consideration. Despite some limitations, the prevalence 
figures estimated in this study provide a basis for the future monitoring of disease trends over 
time and can be used to assess the effectiveness of future disease control programs 
implemented at a national level. 
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Figure 1. Results of antibody titres on unvaccinated farms detected by serological testing of 
bulk milk samples between July 2014 and March 2015 interpreted as a percent positivity or 
percent inhibition (for bovine viral diarrhoea virus). The blue vertical line indicates cut offs 
for negative/positive ELISA results. BVDV = bovine viral diarrhoea virus, MAP = 
Mycobacterium avium subspecies paratuberculosis, BHV-1 = bovine herpes virus 1. 
 
Figure 2. a) The estimated point and overall (period) true prevalence of antibodies against 
Mycobacterium avium subspecies paratuberculosis (MAP) and bovine viral diarrhoea virus 
(BVDV) antigen and 95% confidence intervals of estimates tested using the bulk tank milk 
samples as part of the cross-sectional study (n = 225 dairy farms in Great Britain studied 
between July 2014 and November 2015). For Fasciola hepatica, the estimates and 95% 
confidence intervals of apparent prevalence are presented. Dynamics of tested pathogens: b) 
expressed as proportion of old and new positive farms of the total number of positive farms 
detected at each quarterly test compared to the previous test result of a given pathogen; and c) 
proportion of farms that tested always positive, changed between positive/negative or always 
tested negative during the whole study period (July 2014 to November 2015) 
 
Figure 3. Farmers’ perception of the herd disease status at the time of the visit prior to the 
laboratory testing of bulk milk samples being carried out, accounted for the vaccination 
status. “Believed as present” represents farms where farmers knew the disease was present 
based on the results of previous test or based on their perception. “Believed as problem” 
represents farms where farmers believed that the listed disease was a problem at the time of 
the visit. “Antibody test positive” represents the true proportion of positive unvaccinated 
farms based on the detection of antibodies against tested pathogens using single bulk tank 
milk samples collected between July 2014 and March 2015 (n = 225 dairy farms in Great 
Britain). BVDV = bovine viral diarrhoea virus, MAP = Mycobacterium avium subspecies 
paratuberculosis, BHV-1 = bovine herpes virus 1. 
Figure 4 a,b,c. Choropleth maps showing the proportion of seropositive unvaccinated farms 
by region. The results account for sensitivity and specificity of the tests used, except for 
Coxiella burnetii and studied parasites (n = 225 dairy farms in Great Britain studied as part of 
the cross-sectional study between July 2014 and March 2015). BVDV = bovine viral 
diarrhoea virus, MAP = Mycobacterium avium subspecies paratuberculosis, BHV-1 = bovine 
herpes virus 1. 
 
Figure 5 a,b. Location of low (blue colour) and high (red colour) risk clusters of bulk tank 
milk (BTM) antibody or antigen (bovine viral diarrhoea virus - BVDV) positive unvaccinated 
farms tested using bulk milk tank samples between July 2014 and March 2015 as part of the 
cross-sectional study (n = 225 dairy farms in Great Britain). Relative risk (RR) of significant 
high and low risk clusters (*P < 0.05 and P ≥ 0.01; **P < 0.01).  
 
 
  
Velasova Figure 1 
 
 
 
 
 
 
 
Velasova Figure 2. 
 
 
 
 
 
 
 
 
 
Velasova Figure 3 
 
 
  
1 
Velasova Figure 4a 2 
 3 
 4 
 5 
 6 
Velasova Figure 4b 7 
 8 
 9 
 10 
 11 
Velasova Figure 4c 12 
 13 
 14 
  15 
Velasova Figure 5a 16 
 17 
 18 
 19 
Velasova Figure 5b 20 
 21 
  22 
Table 1. Pathogens for which farm status was assessed by bulk milk testing as part of the 23 
cross-sectional study of 225 dairy farms in Great Britain studied between July 2014 and 24 
November 2015 and criteria used to ascertain farm status  25 
Pathogen (disease) Detection1 
of Ab/Ag 
Diagnostic test Frequency 
of testing 
Bovine Viral Diarrhoea Virus (BVDV) Ab BVDV p80 antibody test, IDEXX 
Laboratories, USA 
Once 
Ag TaqVet® BVDV screening test, LSI, 
France 
Quarterly 
Mycobacterium avium subspecies 
paratuberculosis (Johnes’ disease) 
Ab Paratuberculosis screening test, IDEXX 
Laboratories, USA 
Quarterly 
Leptospira hardjo Ab Bovine Leptospira Hardjo ELISA test, 
Linnodee Ltd, Northern Ireland 
Once 
Bovine herpesvirus type 1 (Infectious 
bovine rhinotracheitis (IBR)) 
Ab BHV-1 Bulk milk antibody test, IDEXX 
Laboratories, USA 
Once 
Salmonella spp. Ab PrioCHECK® Salmonella Ab ELISA, 
Prionics Lelystad B.V, Netherlands 
Once 
Coxiella burnetii (Q fever) Ab LSIVet™ Ruminant Q Fever serum/milk 
ELISA, LSI, France 
Once 
Ag In house real-time PCR  Once 
Chlamydia- like organisms Ag In house, real-time 16S Chlamydiales PCR  Once 
Neospora caninum  Ab SVANOVIR® Neospora- Ab test, 
Svanova, Sweden 
Once 
Fasciola hepatica (Liver fluke) Ab Fasciolosis verification antibody test, 
IDEXX Laboratories, USA 
Quarterly 
Ostertagia ostertagi (Parasitic 
gastroenteritis, PGE) 
Ab SVANOVIR® Ostertagia- Ab test, 
Svanova, Sweden 
Once 
1Detection: Ab = antibody, Ag = antigen 26 
 27 
Table 2. Information on diagnostic test performance, sensitivity and specificity of commercially available assays used for testing of bulk milk 28 
samples as part of the cross-sectional study of dairy farms in Great Britain (n = 225 farms studied between July 2014 and November 2015) 29 
Commercial test Positive 
cut off 
Results 
calculated as 
Within-herd prevalence 
threshold for a positive cut 
off† 
Herd level 
Sensitivity 
Herd level 
Specificity 
Reference 
BVDV p80 Ab >20 % Inhibition >10% 100 100 Manufacturer 
Paratuberculosis Ab screening test >12.5 % Positivity >3% 85 96 (van Weering et al., 2007) 
Linnoddee Leptosira Hardjo ELISA test >3 % Positivity Not available 94.1 94.8 Manufacturer 
BHV-1 Ab test ≥25 % Positivity Not available 100 99.6 Manufacturer 
PrioChECK® Salmonella Ab bovine ELISA ≥35 % Positivity Not available 99.4 97.9 Manufacturer, (Nyman et al., 2013) 
LSIVet™ Ruminant Q Fever ELISA >30 % Positivity >10% 90 - Manufacturer, (Ryan et al., 2011) 
IDEXX Fasciolis Verification Test >30 % Positivity <20% - - Manufacturer 
SVANOVIR® Neospora- iscom Ab test ≥20 % Positivity >10 - 15% 33.3 97.7 (Frossling et al., 2006) 
SVANOVIR® Ostertagia ostertagi Ab test >0.5 % Positivity Not available - - Manufacturer 
† The minimum within herd prevalence used for establishment of herd sensitivity and specificity 30 
  31 
Table 3. The true herd prevalence estimates for selected pathogens and 95% confidence intervals based on the results of single testing of bulk 32 
milk samples on unvaccinated farms, weighted to account for the study design, carried out between July 2014 and March 2015 as part of the 33 
cross-sectional study of 225 dairy farms in Great Britain 34 
Pathogen1 and type of test (antigen or 
antibody detection in BMT) 
Number of vaccinated 
farms excluded 
from the analysis* 
Number of  farms 
for prevalence 
estimation 
Number of 
positive 
farms 
ELISA readings (expressed as % 
positivity/% inhibition) on positive farms 
Median (min-max) 
Prevalence 
% (95% CI) 
BVDV (antigen) 0 225 9** - 5.2 (1.5-8.9) 
BVDV (antibody)  121 102 61 71.7 (21.7-95.6) 66.3 (55.6-77.1) 
MAP (antibody) 2 222 134 21.3 (12.6-83.9) 68.3 (59.3-77.4) 
Leptospira hardjo (antibody)  112 111 46 26.2 (3.4-80.7) 46.9 (33.9-59.8) 
Bovine herpes virus-1 (antibody)  105 118 71 201.0 (26.4-364.2) 62.4 (52.1-72.7) 
Salmonella spp (antibody)  12 209 90 79.4 (35.2-333.1) 47.6 (39.3-55.8) 
Coxiella burnetii (antibody) NA 221 157 92.8 (30.0-222.2) 79.8 (74.6-84.9) † 
Coxiella burnetii (antigen) NA 220 57 - 28.6 (21.2-36.1) 
Chlamydia-like organisms (antigen) NA 220 69 - 31.0 (23.7-38.3) 
Fasciola hepatica (antibody) NA 224 106 132.5 (30.4-555.1) 55.1 (48.4-61.9) † 
Neospora caninum (antibody) NA 222 99 34 (20.1-94.6) 45.8 (38.1-53.5) † 
Ostertagia ostertagi (antibody) NA 221 209 1.07 (0.5-1.7) 94.9 (91.3-98.4) † 
1Pathogen: BVDV = bovine viral diarrhoea virus; MAP = Mycobacterium avium subspecies paratuberculosis; BMT = bulk milk tank; NA = not applicable 35 
*Farms for which information on vaccination was missing were also excluded from the analysis of prevalence: BVDV (1 farm); MAP (1 farm); Leptospira hardjo (2 farms); 36 
bovine herpes virus-1 (3 farms); Salmonella spp (1 farm) 37 
**Seven out of nine BVDV PCR positive farms were vaccinated  38 
†The estimated apparent prevalence figures where no reliable information on herd level sensitivity and specificity of bulk milk ELISA test was available  39 
Table 4. Correlation between positive status of the tested pathogens measured by Phi1 - correlation coefficient on unvaccinated farms, studied as 
part of the cross-sectional study of 225 dairy farms in Great Britain carried out between July 2014 and March 2015 
Pathogens2  BVDV 
Ag 
BHV-1 MAP L. hardjo Salmonella 
spp. 
C. burnetii 
Ab 
C. burnetii 
Ag 
Chlamydia- 
like 
F. hepatica N. caninum O. ostertagi 
BVDV Ab 0.11 0.30 0.11 0.41 0.17 0.10 0.09 0.04 0.34 0.21 0.21 
BVDV Ag  0.10 0.07 0.03 0.08 0.13 0.03 0.04 0.01 0.04 0.05 
BHV-1   0.34 0.59 0.20 0.06 0.04 0.08 0.17 0.17 0.17 
MAP    0.16 0.09 0.02 0.08 0.10 0.07 0.18 0.05 
L. hardjo     0.28 0.18 0.17 0.00 0.28 0.10 0.12 
Salmonella spp.      0.07 0.02 0.04 0.16 0.12 0.01 
C. burnetii Ab       0.33 0.06 0.06 0.13 0.02 
C. burnetii Ag        0.08 0.04 0.01 0.00 
Chlamydia-like          0.03 0.05 0.07 
F. hepatica          0.04 0.15 
N. caninum           0.05 
1 Phi coefficient was calculated as the square root of chi-square divided by n, the total number of observations; medium (0.3) and large (0.5) effect size in bold letters  
2Pathogens: BVDV = bovine viral diarrhoea virus, BHV – 1 = bovine herpesvirus type 1, MAP = Mycobacterium avium subspecies paratuberculosis, L. hardjo = Leptospira 
hardjo, C. burnetii = Coxiella burnetii, F. hepatica = Fasciola hepatica, N. caninum = Neospora caninum, O. ostertagi = Ostertagia ostertagi 
Ab = antibody, Ag = antigen 
  
Table 5 Multivariable logistic regression analysis of the associations between the studied pathogens1 and region2 and herd size on unvaccinated 
farms. Data collected as part of the cross-sectional survey of 225 dairy farms in Great Britain conducted between July 2014 and March 2015.  
  BVDV Ab (N=102) BHV-1 (N=118) MAP (N=222) L. hardjo (N=111) Salmonella spp 
(N=209) 
  OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Herd size <50 Ref  Ref  Ref  Ref  Ref  
 ≥50-149 0.3 0.0-1.6 1.7 0.5-5.3 1.5 0.5-4.4 0.9 0.2-4.5 2.6 0.8-8.7 
 ≥150 0.2 0.0-1.2 1.4 0.4-4.9 1.0 0.3-3.1 1.0 0.2-5.4 4.3 1.2-14.8* 
Region SE England Ref  Ref  Ref  Ref  Ref  
 SW England 1.9 0.5-7.1 2.6 0.8-8.7 3.3 1.3-8.6* 6.3 0.9-41.9 3.8 1.4-10.3** 
 Midlands 1.9 0.5-6.4 3.5 0.9-12.6 0.9 0.4-2.3 9.1 1.6-49.8* 1.6 0.5-4.9 
 N England 3.8 0.9-15.4 2.3 0.6-8.5 1.1 0.5-2.8 6.3 1.0-38.3* 4.3 1.5-12.4** 
 Scotland 2.1 0.4-11.8 6.2 1.1-36.2* 0.8 0.3-2.2 28.3 4.4-183.3*** 6.2 1.8-22.0** 
 Wales 14.2 2.7-74.9** 4.3 1.3-14.0* 1.9 0.8-4.7 32.2 6.0-173.9*** 7.1 2.6-19.6*** 
            
  C. burnetii Ab (N=221) C. burnetii Ag (N=220) Chlamydia-like 
(N=220) 
F. hepatica (N=224) N. caninum (N=220) 
  OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Herd size <50 Ref  Ref  Ref  Ref  Ref  
 ≥50-149 2.9 1.0-8.5* 2.9 1.0-8.5* 2.9 0.6-13.8 0.3 0.1-1.2 1.2 0.4-3.4 
 ≥150 9.6 3.0-30.6*** 9.6 3.0-30.6*** 4.1 0.8-19.7 0.2 0.1-0.9* 1.5 0.5-4.4 
Region SE England Ref  Ref  Ref  Ref  Ref  
 SW England 6.3 2.2-18.0** 6.3 2.2-18.0** 0.7 0.3-1.9 9.6 2.9-31.6*** 1.5 0.6-3.4 
 Midlands 4.2 1.5-12.2** 4.2 1.5-12.2** 0.6 0.2-1.8 2.1 0.5-8.1 1.3 0.5-3.2 
 N England 4.3 1.5-12.1** 4.3 1.5-12.1** 0.3 0.1-1.0 28.0 7.7-101.3*** 1.5 0.6-3.6 
 Scotland 2.8 0.8-9.3 2.8 0.8-9.3 1.4 0.4-4.2 199.0 20.7-1923.0*** 0.5 0.2-1.7 
 Wales 3.9 1.5-10.4** 3.9 1.5-10.4** 1.6 0.7-3.9 12.8 3.8-42.5*** 1.3 0.5-3.1 
1BVDV = bovine viral diarrhoea virus; MAP = Mycobacterium avium subspecies paratuberculosis, BHV-1 = bovine herpesvirus type 1, L. hardjo = Leptospira hardjo,  
C. burnetii = Coxiella burnetii, F. hepatica = Fasciola hepatica, N. caninum = Neospora caninum 
Ab = antibody, OR = odds ratio, CI: Confidence interval, *0.01 < P < 0.05, **0.001 < P < 0.01, ***P < 0.001 
2Region: SE = South East, SW = South West, N = North 
 
  
Table 6. Farmers’ perception of the disease status expressed as positive and negative 1 
predictive values using the bulk milk results as the gold standard. The perception was 2 
recorded at the time of the visit prior to the single laboratory testing of the bulk milk samples 3 
carried out as part of the cross-sectional study of 225 dairy farms in Great Britain carried out 4 
between July 2014 and March 2015 5 
Pathogen1 and type of test (antigen or antibody detection 
in bulk milk sample) 
Farmers’ perception of current disease status2 
 N* PPV % NPV % 
BVDV (antigen) All farms 202 5.0 95.9 
BVDV (antibody) Unvaccinated 92 92.3 53.0 
MAP (antibody) Unvaccinated 204 70.7 51.0 
Leptospira hardjo (antibody) Unvaccinated 98 75.0 70.5 
Bovine herpes virus-1 (antibody) Unvaccinated 93 75.0 46.6 
Salmonella spp (antibody) Unvaccinated 157 68.7 63.2 
Coxiella burnetii (antibody) All farms 75 100.0 31.5 
Coxiella burnetii (antigen) All farms 75 100.0 80.8 
Fasciola hepatica (antibody) All farms 192 64.9 73.5 
Neospora caninum (antibody) All farms 165 61.3 63.1 
Ostertagia ostertagi (antibody) All farms 166 97.2 7.5 
1Pathogens: BVDV = bovine viral diarrhoea virus; MAP = Mycobacterium avium subspecies paratuberculosis 6 
2Farmers’ perception: PPV = positive predictive value; NPV = negative predictive value 7 
*N = number of farms. Farms on which the disease status was unknown were excluded from the calculation of 8 
the PPV and NPV. 9 
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